ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

follitropin delta

Also written as “Follitropin delta”, “FE 999049” and “Follitropin Delta (FE 999049)”.

Its studies are mostly in Infertility · Infertility, Female, led by 3 companies.

Drug pageFollitropin delta: every studyAll 23 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Aug 16, 201318 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Ferring Pharmaceuticals150 open or runningphase 3since Aug 16, 2013Aug 30, 2011none ahead
Clinique Ovoits history only21 open or runningphase 2since Jan 30, 2019Jan 30, 2019none ahead
Dr François Bissonnetteits history only10 open or runningno phasesince Mar 8, 2018Mar 8, 2018none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Ferring Pharmaceuticals only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 30, 2011First study: phase 2 study in InfertilityFirst studyNCT01426386 · 265 enrolled · Belgium, Czechia, Denmark and more
  2. Aug 16, 20132 phase 3 studies in InfertilityNCT01956123, NCT01956110
  3. Nov 28, 2014Phase 2 study in InfertilityNCT02309671 · 159 enrolled · Japan
  4. Jul 13, 2017Phase 3 study in InfertilityNCT03228680 · 373 enrolled · Japan
  5. Sep 14, 2017Phase 3 study in Controlled Ovarian SimulationNCT03296527 · 1,011 enrolled · China, Korea, Republic of, Taiwan and more
  6. May 16, 2018Phase 2 study in Controlled Ovarian StimulationNCT03564509 · 620 enrolled · Belgium, Czechia, Denmark and more
  7. Oct 24, 20182 phase 3 studiesNCT03740737, NCT03738618
  8. Jan 7, 2019Phase 3 study in Infertility, FemaleNCT03809429 · 437 enrolled · Austria, Denmark, Israel and more
  9. Nov 1, 2019Phase 1 study in InfertilityNCT04150861 · 24 enrolled · China
  10. Feb 8, 2021Phase 3 study in InfertilityNCT04773353 · 220 enrolled · India
  11. Nov 16, 2021Phase 3 study in InfertilityNCT05263388 · 302 enrolled · Austria, France, Italy and more
  12. May 30, 2022Phase 2 study in Male Idiopathic InfertilityNCT05403476 · 4 enrolled · United States, Belgium, Denmark and more
  13. Dec 6, 2023Phase 3 study in Infertility, FemaleNCT06173869 · 301 enrolled · China

TargetBeta

FSHR →read by rule
“Follicle stimulating hormone receptor agonist”ChEMBL 37, by rule

Other programs on FSHR

ProgramCompanyFurthest phaseStudies
follitropin alfaruleMerck KGaA, Darmstadt, Germanyphase 426
Follicle Stimulating Hormoneruleglycotope-gmbhphase 46

Studies

All 15 Ferring Pharmaceuticals leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06173869Infertility, Female · China3CompletedMay 31, 2025301
NCT05403476Male Idiopathic Infertility · United States, Belgium, Denmark and more2TerminatedOct 5, 20244
NCT05263388Infertility · Austria, France, Italy and more3CompletedApr 16, 2024302
NCT04773353Infertility · India3CompletedDec 12, 2023220
NCT04150861Infertility · China1CompletedNov 28, 201924
NCT03809429Infertility, Female · Austria, Denmark, Israel and more3CompletedFeb 16, 2022437
NCT03740737Infertility · United States3CompletedNov 11, 2020579
NCT03738618Infertility, Female · United States3CompletedDec 21, 2020588
NCT03564509Controlled Ovarian Stimulation · Belgium, Czechia, Denmark and more2CompletedOct 21, 2019620
NCT03296527Controlled Ovarian Simulation · China, Korea, Republic of, Taiwan and more3CompletedJan 3, 20201,011
NCT03228680Infertility · Japan3CompletedJun 10, 2019373
NCT02309671Infertility · Japan2CompletedNov 2015159
NCT01956123Infertility · Belgium, Brazil, Canada and more3CompletedMay 2015513
NCT01956110Infertility · Belgium, Brazil, Canada and more3CompletedMay 20151,329
NCT01426386Infertility · Belgium, Czechia, Denmark and more2CompletedApr 2012265

How it is read

Names in the registry

  • “Follitropin delta”, 5 entries
  • “FE 999049”, 4 entries
  • “Follitropin Delta (FE 999049)”, 3 entries
  • “Combination therapy : Follitropin delta and HP-hMG”, 1 entry
  • “REKOVELLE (Follitropin Delta)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.